Michael Rosenblatt's most recent trade in Azenta Inc was a trade of 2,465 Common done at an average price of $65.9 . Disclosure was reported to the exchange on Feb. 12, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Azenta Inc | Rosenblatt Michael | Director | 12 Feb 2024 | 2,465 | 13,042 (0%) | 0% | 65.9 | 162,517 | Common | |
Azenta Inc | Michael Rosenblatt | Director | 13 Feb 2023 | 3,604 | 10,577 (0%) | 0% | 0 | Common Stock | ||
Axcella Health Inc | Michael Rosenblatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Azenta Inc | Michael Rosenblatt | Director | 11 Feb 2022 | 1,922 | 6,973 (0%) | 0% | 0 | Common Stock | ||
Azenta Inc | Michael Rosenblatt | Director | 12 Nov 2021 | 2,831 | 5,051 (0%) | 0% | 114.1 | 323,102 | Common Stock | |
Azenta Inc | Michael Rosenblatt | Director | 13 May 2021 | 1,760 | 7,882 (0%) | 0% | 90 | 158,400 | Common Stock | |
Azenta Inc | Michael Rosenblatt | Director | 05 Feb 2021 | 1,760 | 9,642 (0%) | 0% | 0 | Common Stock |